Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Grassroots Cannabis

Explore full profile

Grassroots Cannabis is a grower, processor, and dispenser, of medical cannabis in over four states including Maryland

Chicago, United StatesFounded 2009Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2019
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Grassroots Cannabis and the history behind them.

About Grassroots Cannabis

Grassroots Cannabis established itself as one of the largest private, vertically integrated multi-state cannabis operators in the United States before its acquisition. The company was founded in 2014 by Mitch Kahn, Matt Darin, Steve Weisman, and Josh Joseph, launching its operations in Illinois after the state passed its medical cannabis program. The founders brought a diverse set of experiences to the venture; Kahn had a thirty-year career in real estate investment and business management, Darin was an entrepreneur in commercial real estate, and Weisman had a background in corporate law. This collective expertise in real estate, finance, and law was instrumental in navigating the complex licensing and operational challenges of the burgeoning cannabis market.

The firm operated on a vertically integrated business model, managing the entire lifecycle of its products from cultivation and processing to sales. This structure allowed for rigorous quality control over its cannabis goods, which were developed for both the medical and adult-use markets. Grassroots served a diverse client base, including medical patients seeking therapeutic products and recreational consumers. Its revenue was generated through the direct sale of cannabis products at its dispensaries and wholesale to other retailers. The company’s retail dispensaries operated under brands such as Herbology, Greenhouse, and Windy City Cannabis, offering a wellness and education-focused customer experience.

Grassroots developed an extensive product portfolio that included premium flower, pre-rolls, concentrates like live resin and wax, and various edibles and wellness products such as RSO capsules and tinctures. The company focused on developing unique genetics to produce cannabis with optimal cannabinoid and terpene profiles, catering to seasoned consumers with multidimensional flavors and effects. A significant milestone for Grassroots was its rapid, license-driven expansion across the United States. Starting with just three dispensary licenses in Illinois, the company grew its footprint to include operations in at least eleven states, including key markets like Pennsylvania, Maryland, Ohio, and Michigan. This growth culminated in a landmark event in July 2020, when Grassroots was acquired by Curaleaf Holdings, Inc. for a deal valued at approximately $700-$875 million. The acquisition made Curaleaf the world's largest cannabis company by revenue at the time and integrated the Grassroots leadership team into Curaleaf's management, with Mitch Kahn joining the board and Matt Darin eventually becoming CEO of Curaleaf.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2009
Headquarters
Chicago, United States
Employees
64
Open positions
None listed
Dealroom signal
73.7/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Alternative Medicine, Biotechnology, Cannabis, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jul 2020 $0 — Curaleaf —
EARLY VCOther financing Dec 2019 $0 — Tress Capital —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Grassroots Cannabis website traffic

Latest recorded traffic for Grassroots Cannabis is 9.4K monthly website visits, down 55.2% over the last three months. Grassroots Cannabis's team grew 3.2% over the past year.

Latest monthly visits9.4K 3-month web change-55.2% 1-year team growth+3.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Tress Capital

Other known investors1 additional known investor

  • Curaleaf
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States87.5%
🇮🇳 India6.3%
🇵🇰 Pakistan6.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Grassroots Cannabis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Grassroots Cannabis’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.